Synovial joint fluid cytokine levels in hip disease

Rheumatology (United Kingdom)

Volumn 53, Issue 1, 2014, Pages 165-172

  Abe, Hirohito ^a   Sakai, Takashi ^b   Ando, Wataru ^c   Takao, Masaki ^b   Nishii, Takashi ^a   Nakamura, Nobuo ^d   Hamasaki, Toshimitsu ^b   Yoshikawa, Hideki ^b   Sugano, Nobuhiko ^a  

^a Department of Orthopaedic Medical Engineering ^*  (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KANSAI ROSAI HOSPITAL   (Japan)

^d Kyowakai Hospital   (Japan)

Author keywords

Cytokine; Hip disease; Osteoarthritis; Rapidly destructive coxopathy; Synovial fluid

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEMUR HEAD NECROSIS; FLUORESCENCE; HIP DISEASE; HIP OSTEOARTHRITIS; HOMOGENEOUS TIME RESOLVED FLUORESCENCE; HUMAN; JOINT CAVITY; JOINT DESTRUCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RAPIDLY DESTRUCTIVE COXOPATHY; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIAL FLUID LEVEL; VERY ELDERLY; YOUNG ADULT;

CYTOKINE; HIP DISEASE; OSTEOARTHRITIS; RAPIDLY DESTRUCTIVE COXOPATHY; SYNOVIAL FLUID;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CYTOKINES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; YOUNG ADULT;

EID: 84890941016     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket334     Document Type: Article

References (38)

1. Dewhirst FE, Stashenko PP, Mole JE et al. Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta. J Immunol 1985;135:2562-8.
2. Nakashima T, Kobayashi Y, Yamasaki S et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun 2000;275:768-75.
3. Smolen JS, Beaulieu A, Rubbert-Roth A et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 2008;371:987-97.
4. Weinblatt ME, Kremer JM, Bankhurst AD et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999;340:253-9.
5. Lipsky PE, van der Heijde DM, St Clair EW et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
6. Koch AE, Kunkel SL, Burrows JC et al. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 1991;147:2187-95.
7. Hussein MR, Fathi NA, El-Din AM et al. Alterations of the CD4(+), CD8(+) T cell subsets, interleukins-1beta, IL-10, IL-17, tumor necrosis factor-alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: preliminary observations. Pathol Oncol Res 2008;14:321-8.
8. Postel M, Kerboull M. Total prosthetic replacement in rapidly destructive arthrosis of the hip joint. Clin Orthop Relat Res 1970;72:138-44.
9. Sugano N, Ohzono K, Nishii T et al. Early MRI findings of rapidly destructive coxopathy. Magn Reson Imaging 2001;19:47-50.
10. Berger CE, Kröner A, Stiegler H et al. Elevated levels of serum type I collagen C-telopeptide in patients with rapidly destructive osteoarthritis of the hip. Int Orthop 2005;29:1-5.
11. Ogawa K, Mawatari M, Komine M et al. Mature and activated osteoclasts exist in the synovium of rapidly destructive coxarthrosis. J Bone Miner Metab 2007;25:354-60.
12. Tamai M, Sagawa K, Kawabata R et al. Production of IL-6 by T cells from the femoral head of patients with rapidly destructive coxopathy (RDC). Clin Exp Immunol 1996;103:506-13.
13. Li W, Sakai T, Nishii T et al. Distribution of TRAP-positive cells and expression of HIF-1alpha, VEGF, and FGF-2 in the reparative reaction in patients with osteonecrosis of the femoral head. J Orthop Res 2009;27:694-700.
14. Samara S, Kollia P, Dailiana Z et al. Predictive role of cytokine gene polymorphisms for the development of femoral head osteonecrosis. Dis Markers 2012;33:215-21.
15. Xie J, Naito M, Maeyama A. Intracapsular pressure and interleukin-1beta cytokine in hips with acetabular dysplasia. Acta Orthop 2010;81:189-92.
16. Komiya S, Inoue A, Sasaguri Y et al. Rapidly destructive arthropathy of the hip. Studies on bone resorptive factors in joint fluid with a theory of pathogenesis. Clin Orthop Relat Res 1992;284:273-82.
17. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494-502.
18. Sugano N, Atsumi T, Ohzono K et al. The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head. J Orthop Sci 2002;7:601-5.
19. Take Y, Nakata K, Hashimoto J et al. Specifically modified osteopontin in rheumatoid arthritis fibroblast-like synoviocytes supports interaction with B cells and enhances production of interleukin-6. Arthritis Rheum 2009;60:3591-601.
20. Akamine Y, Kakudo K, Kondo M et al. Prolonged matrix metalloproteinase-3 high expression after cyclic compressive load on human synovial cells in three-dimensional cultured tissue. Int J Oral Maxillofac Surg 2012;41:874-81.
21. Enomoto K, Aono Y, Mitsugi T et al. High throughput screening for human interferon-gamma production inhibitor using homogenous time-resolved fluorescence. J Biomol Screen 2000;5:263-8.
22. Xiu ZB, Chen WT, Sun KM. Study on correlation between the pathological changes under arthroscopy and the cytokine levels in the knee osteoarthritis of the blood stasis type. Zhongguo Gu Shang 2010;23:890-3.
23. Peichl P, Ceska M, Effenberger F et al. Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis. Scand J Immunol 1991;34:333-9.
24. Rampart M, Herman AG, Grillet B et al. Development and application of a radioimmunoassay for interleukin-8: detection of interleukin-8 in synovial fluids from patients with inflammatory joint disease. Lab Invest 1992;66:512-8.
25. Endo H, Akahoshi T, Takagishi K et al. Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res 1991;10:245-52.
26. Lassus J, Waris V, Xu JW et al. Increased interleukin-8 (IL-8) expression is related to aseptic loosening of total hip replacement. Arch Orthop Trauma Surg 2000;120:328-32.
27. Tanaka R, Yasunaga Y, Hisatome T et al. Serum interleukin 8 levels correlate with synovial fluid levels in patients with aseptic loosening of hip prosthesis. J Arthroplasty 2005;20:1049-54.
28. Bendre MS, Montague DC, Peery T et al. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 2003;33:28-37.
29. Boucharaba A, Serre CM, Grès S et al. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest 2004;114:1714-25.
30. Hsu YL, Hung JY, Ko YC et al. Phospholipase D signaling pathway is involved in lung cancer-derived IL-8 increased osteoclastogenesis. Carcinogenesis 2010;31:587-96.
31. Kadoya Y, Kobayashi A, Ohashi H. Wear and osteolysis in total joint replacements. Acta Orthop Scand Suppl 1998;278:1-16.
32. Matsukawa A, Yoshimura T, Maeda T et al. Neutrophil accumulation and activation by homologous IL-8 in rabbits. IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo. J Immunol 1995;154:5418-25.
33. Benoy IH, Salgado R, Van Dam P et al. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res 2004;10:7157-62.
34. Lehrer S, Diamond EJ, Mamkine B et al. Serum interleukin-8 is elevated in men with prostate cancer and bone metastases. Technol Cancer Res Treat 2004;3:411.
35. Mitrovic DR, Riera H. Synovial, articular cartilage, and bone changes in rapidly destructive arthropathy (osteoarthritis) of the hip. Rheumatol Int 1992;12:17-22.
36. Rosenberg ZS, Shankman S, Steiner GC et al. Rapid destructive osteoarthritis: clinical, radiographic, and pathologic features. Radiology 1992;182:213-6.
37. Ryu KN, Kim EJ, Yoo MC et al. Ischemic necrosis of the entire femoral head and rapidly destructive hip disease: potential causative relationship. Skeletal Radiol 1997;26:143-9.
38. Cameron HU, MacNab I. Observations on osteoarthritis of the hip joint. Clin Orthop 1975;108:31-40.